Jeffrey J. Jones's most recent trade in Cohu, Inc. was a trade of 10,587 Performance Stock Units done . Disclosure was reported to the exchange on March 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Other type of transaction at price $ 0.00 per share. | 14 Mar 2025 | 10,587 | 347,312 | - | 0 | Performance Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Mar 2025 | 8,362 | 338,950 (0%) | 0% | 0 | Common Stock | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Mar 2025 | 1,291 | 337,659 (0%) | 0% | 0 | Common Stock | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 45,500 | 361,182 | - | 0 | Performance Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 30,333 | 315,682 (0%) | 0% | 0 | Restricted Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Mar 2025 | 3,283 | 357,899 (0%) | 0% | 0 | Common Stock | |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 25 Feb 2025 | 4,895 | 174,164 | - | 8.5 | 41,754 | Common Stock |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 65,000 | 179,059 | - | 0 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 5,452 | 98,244 (0%) | 0% | 0 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 31 Jan 2025 | 2,991 | 95,975 (0%) | 0% | 24.3 | 72,621 | Common Stock |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 788 | 96,763 (0%) | 0% | 0 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 722 | 98,966 (0%) | 0% | 0 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | Grant, award, or other acquisition of securities at price $ 24.52 per share. | 31 Jan 2025 | 64 | 6,599 (0%) | 0% | 24.5 | 1,569 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 49.29 per share. | 24 Jan 2025 | 52 | 11,926 (0%) | 0% | 49.3 | 2,563 | Common Stock |
Whitestone REIT | Alan Jones Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 14.15 per share. | 24 Dec 2024 | 5,831 | 33,110 (0%) | 0% | 14.2 | 82,509 | Common Shares |
Cullinan Oncology Inc | Jeffrey Jones Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 18 Dec 2024 | 4,632 | 114,059 | - | 11.4 | 52,851 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Purchase of securities on an exchange or from another person at price $ 36.88 per share. | 25 Oct 2024 | 69 | 11,874 (0%) | 0% | 36.9 | 2,545 | Common Stock |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 25,000 | 126,256 | - | - | Stock Option (Right to Buy) | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.31 per share. | 31 Aug 2024 | 175,304 | 902,891 (0%) | 0% | 63.3 | 11,098,496 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 45,886 | 1,078,195 (0%) | 0% | 0 | Common Stock | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 63.07 per share. | 31 Aug 2024 | 9,722 | 893,169 (0%) | 0% | 63.1 | 613,167 | Common Stock |
Visteon Corp. | Jeffrey D. Jones | Director | Sale of securities on an exchange or to another person at price $ 97.02 per share. | 16 Aug 2024 | 401 | 1,532 (0%) | 0% | 97.0 | 38,905 | Common Stock |
Visteon Corp. | Jeffrey D. Jones | Director | Sale of securities on an exchange or to another person at price $ 97.10 per share. | 16 Aug 2024 | 200 | 1,332 (0%) | 0% | 97.1 | 19,420 | Common Stock |
Visteon Corp. | Jeffrey D. Jones | Director | Sale of securities on an exchange or to another person at price $ 96.95 per share. | 16 Aug 2024 | 100 | 1,933 (0%) | 0% | 97.0 | 9,695 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 318,031 | 1,032,309 (0%) | 0% | 0 | Common Stock | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 148,088 | 862,366 (0%) | 0% | 0 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 30 Jul 2024 | 752 | 92,792 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 30 Jul 2024 | 55 | 6,535 (0%) | 0% | 28.3 | 1,555 | Common Stock | |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 61.83 per share. | 26 Jul 2024 | 41 | 11,804 (0%) | 0% | 61.8 | 2,535 | Common Stock |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2024 | 45,000 | 0 | - | - | Stock Option (Right to Buy) | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2024 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.55 per share. | 01 Jul 2024 | 44,975 | 712,385 (0%) | 0% | 54.5 | 2,453,197 | Common Stock |
Visteon Corp. | Jeffrey D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,396 | 1,396 | - | - | Restricted Stock Units | |
Visteon Corp. | Jeffrey D. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 841 | 0 | - | - | Restricted Stock Units | |
Visteon Corp. | Jeffrey D. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 841 | 2,033 (0%) | 0% | - | Common Stock | |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 65.22 per share. | 04 Jun 2024 | 2,530 | 11,763 (0%) | 0% | 65.2 | 165,000 | Common Stock |
Summit Hotel Properties Inc | Jeffrey W. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2024 | 18,213 | 117,424 (0%) | 0% | 0 | Common Stock | |
Noodles & Company - Ordina... | Jeffrey W. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 40,540 | 186,407 (0%) | 0% | 0 | Class A Common Stock | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 45,000 | 101,256 | - | - | Stock Option (Right to Buy) | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 01 May 2024 | 635 | 92,040 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 01 May 2024 | 67 | 6,480 (0%) | 0% | 23.0 | 1,539 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 01 May 2024 | 17 | 91,405 (0%) | 0% | 23.9 | 406 | Common Stock | |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 75.84 per share. | 26 Apr 2024 | 25 | 9,232 (0%) | 0% | 75.8 | 1,896 | Common Stock |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 28 Mar 2024 | 1,004 | 6,413 (0%) | 0% | 20.5 | 20,541 | Common Stock | |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 28 Mar 2024 | 782 | 91,388 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 20 Mar 2024 | 10,171 | 90,606 (0%) | 0% | 0 | Common Stock | ||
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Mar 2024 | 3,495 | 285,349 | - | 0 | Restricted Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Mar 2024 | 5,541 | 288,844 (0%) | 0% | 0 | Common Stock | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 14 Mar 2024 | 4,231 | 295,549 (0%) | 0% | 0 | Common Stock | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Other type of transaction at price $ 0.00 per share. | 14 Mar 2024 | 1,164 | 294,385 | - | 0 | Performance Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 24,474 | 299,780 | - | 0 | Performance Stock Units | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 16,316 | 275,306 | - | 0 | Restricted Stock Units | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 25,000 | 56,256 | - | - | Stock Option (Right to Buy) | |
H&R Block Inc. | Jeffrey Jones J. | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 49.21 per share. | 23 Feb 2024 | 85,921 | 755,359 (0%) | 0% | 49.2 | 4,228,593 | Common Stock |
Visteon Corp. | Jones D. Jeffrey | Director | Sale of securities on an exchange or to another person at price $ 115.23 per share. | 23 Feb 2024 | 1,000 | 1,192 (0%) | 0% | 115.2 | 115,230 | Common Stock |
Cullinan Oncology Inc | Alan Jones Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
Cullinan Oncology Inc | Jones Alan Jeffrey | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 62,500 | 118,691 | - | 0 | Common Stock | |
H&R Block Inc. | Jeffrey Jones J. | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 48.02 per share. | 15 Feb 2024 | 14,938 | 841,280 (0%) | 0% | 48.0 | 717,353 | Common Stock |
Advance Auto Parts Inc | Jones J. Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 67.46 per share. | 26 Jan 2024 | 28 | 9,207 (0%) | 0% | 67.5 | 1,889 | Common Stock |
First Busey Corp. | Jones Jeffrey D. | EVP & CFO | 23 Jan 2024 | 2,588 | 81,331 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | D. Jones Jeffrey | EVP & CFO | 23 Jan 2024 | 896 | 80,435 (0%) | 0% | 23.9 | 21,379 | Common Stock | |
First Busey Corp. | Jones D. Jeffrey | EVP & CFO | 23 Jan 2024 | 52 | 5,408 (0%) | 0% | 24.7 | 1,286 | Common Stock | |
First Busey Corp. | Jeffrey Jones D. | EVP & CFO | 29 Dec 2023 | 623 | 78,743 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | D. Jeffrey Jones | EVP & CFO | 29 Dec 2023 | 65 | 5,356 (0%) | 0% | 19.5 | 1,270 | Common Stock | |
Cullinan Oncology Inc | Jones Jeffrey Alan | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 21 Dec 2023 | 1,860 | 56,191 | - | 8.5 | 15,810 | Common Stock |
Whitestone REIT | Alan Jeffrey Jones | Director | Grant, award, or other acquisition of securities at price $ 12.44 per share. | 20 Dec 2023 | 4,824 | 27,279 (0%) | 0% | 12.4 | 60,011 | Common Shares |
Cullinan Oncology Inc | Jones Alan Jeffrey | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.22 per share. | 18 Dec 2023 | 386 | 58,051 | - | 8.2 | 3,173 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 50.78 per share. | 27 Oct 2023 | 37 | 9,179 (0%) | 0% | 50.8 | 1,879 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 61,281 | 873,430 (0%) | 0% | 0 | Common Stock | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.98 per share. | 31 Aug 2023 | 21,691 | 851,739 (0%) | 0% | 40.0 | 867,206 | Common Stock |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 31,256 | 31,256 | - | - | Stock Option (Right to Buy) | |
Cutera Inc | Jeffrey S. Jones | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 12,306 | 12,306 (0%) | 0% | 0 | Common Stock | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 38.00 per share. | 16 Aug 2023 | 91,192 | 812,149 (0%) | 0% | 38 | 3,465,296 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 76.04 per share. | 28 Jul 2023 | 25 | 9,141 (0%) | 0% | 76.0 | 1,901 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 579,702 | 1,165,947 (0%) | 0% | 0 | Common Stock | |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.61 per share. | 19 Jul 2023 | 262,606 | 903,341 (0%) | 0% | 33.6 | 8,826,188 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.10 per share. | 07 Jul 2023 | 123 | 586,244 (0%) | 0% | 31.1 | 3,825 | Common Stock |
H&R Block Inc. | Jeffrey J. Jones | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.87 per share. | 30 Jun 2023 | 13,053 | 583,474 (0%) | 0% | 31.9 | 415,999 | Common Stock |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 30 Jun 2023 | 693 | 77,331 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 30 Jun 2023 | 67 | 5,233 (0%) | 0% | 0 | Common Stock | ||
Visteon Corp. | Jeffrey D. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 1,189 | 0 | - | - | Restricted Stock Units | |
Visteon Corp. | Jeffrey D. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 1,189 | 2,192 (0%) | 0% | - | Common Stock | |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.94 per share. | 20 Jun 2023 | 387 | 58,437 | - | 12.9 | 5,008 | Common Stock |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 14 Jun 2023 | 10,000 | 258,990 (0%) | 0% | 40 | 400,000 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 66.91 per share. | 12 Jun 2023 | 2,466 | 9,115 (0%) | 0% | 66.9 | 165,000 | Common Stock |
Visteon Corp. | Jeffrey D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 841 | 841 | - | - | Restricted Stock Units | |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Purchase of securities on an exchange or from another person at price $ 65.94 per share. | 07 Jun 2023 | 1,525 | 6,648 (0%) | 0% | 65.9 | 100,559 | Common Stock |
Summit Hotel Properties Inc | Jeffrey W. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 16,163 | 99,211 (0%) | 0% | 0 | Common Stock | |
Noodles & Company - Ordina... | Jeffrey W. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2023 | 40,540 | 145,867 (0%) | 0% | 0 | Class A Common Stock | |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.76 per share. | 18 May 2023 | 394 | 58,824 | - | 8.8 | 3,451 | Common Stock |
Advance Auto Parts Inc | Jeffrey J. Jones | Director | Grant, award, or other acquisition of securities at price $ 126.25 per share. | 28 Apr 2023 | 59 | 5,123 (0%) | 0% | 126.3 | 7,449 | Common Stock |
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Apr 2023 | 392 | 59,218 | - | 10.7 | 4,198 | Common Stock |
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 31 Mar 2023 | 1,059 | 5,165 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 31 Mar 2023 | 809 | 76,638 (0%) | 0% | 0 | Common Stock | ||
First Busey Corp. | Jeffrey D. Jones | EVP & CFO | 22 Mar 2023 | 11,008 | 75,829 (0%) | 0% | 0 | Common Stock | ||
Cullinan Oncology Inc | Jeffrey Alan Jones | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.32 per share. | 20 Mar 2023 | 390 | 59,610 | - | 11.3 | 4,415 | Common Stock |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Mar 2023 | 22,024 | 271,754 (0%) | 0% | 0 | Common Stock | |
Cohu, Inc. | Jeffrey D. Jones | Sr. VP Finance & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 17 Mar 2023 | 2,764 | 268,990 (0%) | 0% | 0 | Common Stock |